Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 CDK4 5件: PI3K-Akt signaling pathway, Tight junction, T cell receptor signaling pathway, Viral carcinogenesis, Small cell lung cancer D10688 Abemaciclib 1件: 34
2 CDK6 3件: PI3K-Akt signaling pathway, Viral carcinogenesis, Small cell lung cancer D10688 Abemaciclib 1件: 34
3 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00113 Atropine 2件: 2, 299
4 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00138 Scopolamine 1件: 2
5 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00270 Chlorpromazine 1件: 254
6 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00397 Tropicamide 3件: 6, 13, 19
7 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00465 Oxybutynin 3件: 6, 13, 53
8 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00481 Propantheline 1件: 26
9 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00722 Oxybutynin 3件: 6, 13, 53
10 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00765 Rocuronium 1件: 296
11 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00787 Trihexyphenidyl 2件: 5, 6
12 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00789 Chlorpromazine 1件: 254
13 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D01000 Bethanechol 1件: 98
14 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D01077 Atropine 2件: 2, 299
15 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D02069 Atropine 2件: 2, 299
16 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D02212 Ipratropium 2件: 6, 86
17 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D03011 Atropine 2件: 2, 299
18 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D03274 Chlorpromazine 1件: 254
19 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D03814 Atropine 2件: 2, 299
20 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D04034 Chlorpromazine 1件: 254
21 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08441 Propiverine 1件: 226
22 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08638 Trihexyphenidyl 2件: 5, 6
23 CHRM1 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D11383 Blarcamesine 1件: 156
24 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00113 Atropine 2件: 2, 299
25 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00138 Scopolamine 1件: 2
26 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00270 Chlorpromazine 1件: 254
27 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00397 Tropicamide 3件: 6, 13, 19
28 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00465 Oxybutynin 3件: 6, 13, 53
29 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00481 Propantheline 1件: 26
30 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00525 Pilocarpine 3件: 6, 53, 299
31 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00722 Oxybutynin 3件: 6, 13, 53
32 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00765 Rocuronium 1件: 296
33 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00787 Trihexyphenidyl 2件: 5, 6
34 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00789 Chlorpromazine 1件: 254
35 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D01000 Bethanechol 1件: 98
36 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D01077 Atropine 2件: 2, 299
37 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D02069 Atropine 2件: 2, 299
38 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D02200 Pilocarpine 3件: 6, 53, 299
39 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D02212 Ipratropium 2件: 6, 86
40 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D03011 Atropine 2件: 2, 299
41 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D03274 Chlorpromazine 1件: 254
42 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D03814 Atropine 2件: 2, 299
43 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D04034 Chlorpromazine 1件: 254
44 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D05478 Pilocarpine 3件: 6, 53, 299
45 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D07226 Fesoterodine 1件: 6
46 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08441 Propiverine 1件: 226
47 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08638 Trihexyphenidyl 2件: 5, 6
48 CHRM2 2件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D11383 Blarcamesine 1件: 156
49 CSF1 6件: Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, TNF signaling pathway, Rheumatoid arthritis D06402 Sunitinib 2件: 28, 34
50 CSF1 6件: Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, TNF signaling pathway, Rheumatoid arthritis D08552 Sunitinib 2件: 28, 34
51 CSF1R 5件: Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D11270 Pexidartinib 1件: 34
52 CSF3R 1件: PI3K-Akt signaling pathway D03235 Filgrastim 34件: 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331
53 CSF3R 1件: PI3K-Akt signaling pathway D03247 Lenograstim 7件: 2, 13, 16, 18, 19, 57, 65
54 CSF3R 1件: PI3K-Akt signaling pathway D06889 Pegfilgrastim 1件: 60
55 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D01977 Gefitinib 1件: 75
56 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D03455 Cetuximab 5件: 34, 51, 86, 89, 331
57 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D04023 Erlotinib 1件: 94
58 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D04024 Lapatinib 3件: 34, 74, 75
59 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D07907 Erlotinib 1件: 94
60 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D08108 Lapatinib 3件: 34, 74, 75
61 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D11251 Icotinib 1件: 34
62 EGFR 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer D11772 Tesevatinib 1件: 67
63 EPHA2 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D03658 Dasatinib 2件: 51, 85
64 EPHA2 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D06414 Dasatinib 2件: 51, 85
65 EPOR 1件: PI3K-Akt signaling pathway D03231 Erythropoietin 10件: 2, 6, 13, 18, 22, 46, 47, 70, 95, 96
66 EPOR 1件: PI3K-Akt signaling pathway D09946 Peginesatide 1件: 283
67 ERBB2 5件: Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Proteoglycans in cancer, Prostate cancer D04024 Lapatinib 3件: 34, 74, 75
68 ERBB2 5件: Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Proteoglycans in cancer, Prostate cancer D08108 Lapatinib 3件: 34, 74, 75
69 ERBB2 5件: Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Proteoglycans in cancer, Prostate cancer D11772 Tesevatinib 1件: 67
70 FGFR1 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Proteoglycans in cancer, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
71 FGFR1 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Proteoglycans in cancer, Prostate cancer D11589 Infigratinib 1件: 276
72 FGFR3 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D10481 Nintedanib 5件: 51, 85, 89, 227, 228
73 FGFR3 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D11589 Infigratinib 1件: 276
74 FGFR2 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Prostate cancer D05338 Palifermin 5件: 13, 36, 38, 39, 65
75 FGFR2 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
76 FGFR2 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Prostate cancer D11589 Infigratinib 1件: 276
77 FLT1 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D03218 Axitinib 1件: 34
78 FLT1 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D06402 Sunitinib 2件: 28, 34
79 FLT1 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D08552 Sunitinib 2件: 28, 34
80 FLT1 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D08881 Cediranib 1件: 34
81 FLT1 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D10481 Nintedanib 5件: 51, 85, 89, 227, 228
82 FLT3 3件: Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D06272 Sorafenib 2件: 34, 86
83 FLT3 3件: Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D06402 Sunitinib 2件: 28, 34
84 FLT3 3件: Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D08524 Sorafenib 2件: 34, 86
85 FLT3 3件: Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D08552 Sunitinib 2件: 28, 34
86 FLT3 3件: Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D11270 Pexidartinib 1件: 34
87 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D03218 Axitinib 1件: 34
88 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D06272 Sorafenib 2件: 34, 86
89 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D06402 Sunitinib 2件: 28, 34
90 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08524 Sorafenib 2件: 34, 86
91 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08552 Sunitinib 2件: 28, 34
92 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08881 Cediranib 1件: 34
93 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D10481 Nintedanib 5件: 51, 85, 89, 227, 228
94 FLT4 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D11772 Tesevatinib 1件: 67
95 MTOR 9件: PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer D00753 Sirolimus 41件: 2, 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331
96 MTOR 9件: PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer D02714 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277
97 MTOR 9件: PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer D06068 Temsirolimus 4件: 13, 34, 89, 331
98 GHR 1件: PI3K-Akt signaling pathway D02691 Somatotropin 23件: 2, 3, 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299
99 GHR 1件: PI3K-Akt signaling pathway D03297 Mecasermin 6件: 65, 78, 96, 168, 265, 299
100 GHR 1件: PI3K-Akt signaling pathway D04870 Mecasermin 6件: 65, 78, 96, 168, 265, 299
101 GHR 1件: PI3K-Akt signaling pathway D05394 Pegvisomant 1件: 78
102 GHR 1件: PI3K-Akt signaling pathway D11193 Somavaratan 1件: 78
103 GHR 1件: PI3K-Akt signaling pathway D11194 Somapacitan 1件: 78
104 GHR 1件: PI3K-Akt signaling pathway D11486 Lonapegsomatropin 1件: 78
105 IFNA1 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
106 IFNA1 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
107 IFNA2 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
108 IFNA2 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
109 IFNA4 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
110 IFNA4 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
111 IFNA5 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
112 IFNA5 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
113 IFNA6 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
114 IFNA6 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
115 IFNA7 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
116 IFNA7 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
117 IFNA8 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
118 IFNA8 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
119 IFNA10 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
120 IFNA10 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
121 IFNA13 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
122 IFNA13 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
123 IFNA14 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
124 IFNA14 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
125 IFNA16 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
126 IFNA16 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
127 IFNA17 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
128 IFNA17 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
129 IFNA21 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09662 Rontalizumab 1件: 49
130 IFNA21 4件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis D09668 Sifalimumab 1件: 49
131 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D00745 Interferon alfa-2a 1件: 56
132 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D00746 Interferon beta-1b 1件: 13
133 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D02745 Interferon alfa-2b 2件: 25, 34
134 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D03305 Interferon alfa 6件: 13, 25, 26, 28, 56, 96
135 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D04554 Interferon beta-1a 4件: 13, 26, 96, 97
136 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D10483 Peginterferon beta-1a 1件: 13
137 IFNAR1 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D11082 Anifrolumab 2件: 46, 49
138 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D00745 Interferon alfa-2a 1件: 56
139 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D00746 Interferon beta-1b 1件: 13
140 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D02745 Interferon alfa-2b 2件: 25, 34
141 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D03305 Interferon alfa 6件: 13, 25, 26, 28, 56, 96
142 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D04554 Interferon beta-1a 4件: 13, 26, 96, 97
143 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D10483 Peginterferon beta-1a 1件: 13
144 IFNAR2 2件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway D11082 Anifrolumab 2件: 46, 49
145 IGF1R 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D03297 Mecasermin 6件: 65, 78, 96, 168, 265, 299
146 IGF1R 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D04870 Mecasermin 6件: 65, 78, 96, 168, 265, 299
147 IGF1R 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D09680 Teprotumumab 1件: 51
148 IGF1R 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D09925 Linsitinib 1件: 232
149 IL2RA 4件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
150 IL2RA 4件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation D03058 Basiliximab 6件: 2, 50, 66, 97, 222, 228
151 IL2RA 4件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation D03639 Daclizumab 8件: 13, 56, 60, 65, 97, 107, 283, 284
152 IL2RB 5件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
153 IL2RG 5件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Primary immunodeficiency D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
154 IL4 4件: PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway D03117 Binetrakin 1件: 46
155 IL4R 3件: PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation D10354 Dupilumab 4件: 51, 98, 160, 162
156 IL6 11件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
157 IL6 11件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D08976 Pomalidomide 6件: 28, 34, 51, 85, 227, 331
158 IL6 11件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D09669 Siltuximab 2件: 28, 331
159 IL6 11件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D10080 Sirukumab 2件: 41, 46
160 IL6R 3件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation D02596 Tocilizumab 21件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331
161 IL6R 3件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation D10161 Sarilumab 5件: 41, 46, 84, 107, 271
162 IL6R 3件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation D11079 Satralizumab 2件: 11, 13
163 INSR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D00085 Insulin human 2件: 96, 156
164 INSR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D03230 Insulin human 2件: 96, 156
165 INSR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D03250 Insulin glargine 1件: 299
166 INSR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D04539 Insulin detemir 1件: 299
167 ITGA4 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection D06590 Firategrast 1件: 13
168 ITGA4 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection D06886 Natalizumab 6件: 13, 15, 25, 46, 63, 96
169 ITGA4 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection D08083 Vedolizumab 3件: 94, 96, 97
170 ITGA4 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection D10540 Abrilumab 2件: 96, 97
171 ITGB7 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer D08083 Vedolizumab 3件: 94, 96, 97
172 ITGB7 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer D09901 Etrolizumab 2件: 96, 97
173 ITGB7 3件: PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer D10540 Abrilumab 2件: 96, 97
174 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09959 Ruxolitinib 1件: 228
175 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
176 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10308 Baricitinib 13件: 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
177 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10653 Peficitinib 1件: 46
178 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10871 Filgotinib 6件: 46, 53, 96, 97, 222, 271
179 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10944 Itacitinib 5件: 46, 51, 60, 97, 228
180 JAK1 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10994 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271
181 JAK2 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis D09959 Ruxolitinib 1件: 228
182 JAK2 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
183 JAK2 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis D10308 Baricitinib 13件: 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
184 JAK2 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis D10653 Peficitinib 1件: 46
185 JAK3 6件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis, Primary immunodeficiency D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
186 JAK3 6件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis, Primary immunodeficiency D10653 Peficitinib 1件: 46
187 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D03218 Axitinib 1件: 34
188 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D06272 Sorafenib 2件: 34, 86
189 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D06402 Sunitinib 2件: 28, 34
190 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D08524 Sorafenib 2件: 34, 86
191 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D08552 Sunitinib 2件: 28, 34
192 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D08881 Cediranib 1件: 34
193 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D10062 Cabozantinib 1件: 34
194 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
195 KDR 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer D11772 Tesevatinib 1件: 67
196 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D01441 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
197 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D03658 Dasatinib 2件: 51, 85
198 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D06272 Sorafenib 2件: 34, 86
199 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D06402 Sunitinib 2件: 28, 34
200 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D06414 Dasatinib 2件: 51, 85
201 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
202 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08524 Sorafenib 2件: 34, 86
203 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08552 Sunitinib 2件: 28, 34
204 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D08953 Nilotinib 5件: 6, 8, 34, 51, 86
205 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D10229 Masitinib 6件: 2, 5, 6, 13, 46, 96
206 KIT 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D11270 Pexidartinib 1件: 34
207 MET 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Proteoglycans in cancer, Renal cell carcinoma D10062 Cabozantinib 1件: 34
208 NFKB1 20件: Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer D01146 Iguratimod 4件: 46, 51, 53, 271
209 NGF 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D09387 Tanezumab 2件: 226, 298
210 NGFR 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer D11028 Cenegermin 2件: 53, 90
211 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D01441 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
212 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D06402 Sunitinib 2件: 28, 34
213 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
214 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08552 Sunitinib 2件: 28, 34
215 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08953 Nilotinib 5件: 6, 8, 34, 51, 86
216 PDGFRA 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
217 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D03658 Dasatinib 2件: 51, 85
218 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D06272 Sorafenib 2件: 34, 86
219 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D06402 Sunitinib 2件: 28, 34
220 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D06414 Dasatinib 2件: 51, 85
221 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08524 Sorafenib 2件: 34, 86
222 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08552 Sunitinib 2件: 28, 34
223 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D08953 Nilotinib 5件: 6, 8, 34, 51, 86
224 PDGFRB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
225 PGF 3件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway D09574 Aflibercept 2件: 90, 166
226 PIK3CA 28件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer D11158 Leniolisib 2件: 53, 65
227 PIK3CB 28件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer D11158 Leniolisib 2件: 53, 65
228 PIK3CD 28件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer D11158 Leniolisib 2件: 53, 65
229 PIK3CD 28件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer D11437 Parsaclisib 3件: 35, 53, 61
230 PRKAA1 3件: PI3K-Akt signaling pathway, Tight junction, Thermogenesis D00944 Metformin 24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
231 PRKAA1 3件: PI3K-Akt signaling pathway, Tight junction, Thermogenesis D04966 Metformin 24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
232 PRKAA2 3件: PI3K-Akt signaling pathway, Tight junction, Thermogenesis D00944 Metformin 24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
233 PRKAA2 3件: PI3K-Akt signaling pathway, Tight junction, Thermogenesis D04966 Metformin 24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
234 MAP2K1 22件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D09666 Selumetinib 1件: 34
235 MAP2K1 22件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10175 Trametinib 4件: 2, 34, 279, 280
236 MAP2K1 22件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10405 Cobimetinib 1件: 280
237 MAP2K1 22件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10604 Binimetinib 1件: 34
238 MAP2K2 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D09666 Selumetinib 1件: 34
239 MAP2K2 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10175 Trametinib 4件: 2, 34, 279, 280
240 MAP2K2 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10405 Cobimetinib 1件: 280
241 MAP2K2 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10604 Binimetinib 1件: 34
242 PRL 2件: PI3K-Akt signaling pathway, Prolactin signaling pathway D00780 Bromocriptine 2件: 6, 74
243 PRL 2件: PI3K-Akt signaling pathway, Prolactin signaling pathway D00987 Cabergoline 3件: 6, 74, 75
244 PRL 2件: PI3K-Akt signaling pathway, Prolactin signaling pathway D01348 Terguride 2件: 51, 86
245 PRL 2件: PI3K-Akt signaling pathway, Prolactin signaling pathway D03165 Bromocriptine 2件: 6, 74
246 RAF1 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Tuberculosis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer D06272 Sorafenib 2件: 34, 86
247 RAF1 19件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Tuberculosis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer D08524 Sorafenib 2件: 34, 86
248 BCL2 10件: Platinum drug resistance, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Shigellosis, Salmonella infection, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer D10679 Venetoclax 1件: 28
249 RELA 20件: Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer D12181 Edasalonexent 1件: 113
250 RXRA 7件: PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02754 Acitretin 1件: 37
251 RXRA 7件: PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02815 Alitretinoin 1件: 49
252 RXRA 7件: PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D03106 Bexarotene 2件: 13, 75
253 SYK 4件: PI3K-Akt signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis D09347 Fostamatinib 4件: 46, 49, 61, 66
254 VEGFA 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D05697 Ranibizumab 4件: 34, 166, 227, 301
255 VEGFA 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D06409 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331
256 VEGFA 8件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D09574 Aflibercept 2件: 90, 166
257 VEGFB 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Relaxin signaling pathway D09574 Aflibercept 2件: 90, 166
258 VWF 2件: PI3K-Akt signaling pathway, Platelet activation D11160 Caplacizumab 1件: 64
259 FGF23 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D10913 Burosumab 1件: 238
260 CASP9 10件: Platinum drug resistance, PI3K-Akt signaling pathway, VEGF signaling pathway, Thyroid hormone signaling pathway, Prion disease, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer, Viral myocarditis D11195 Rimiducid 6件: 19, 60, 65, 284, 285, 326
261 CD19 2件: PI3K-Akt signaling pathway, Primary immunodeficiency D11757 Inebilizumab 4件: 11, 13, 51, 300